Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases
ABSTRACTObjective: An association exists between immune checkpoint inhibitors and hemophagocytic lymphohistiocytosis (HLH). Therefore, the main objective of this study was to collect data on this rare but potentially life-threatening immune-related adverse reaction to identify the medications that c...
Main Authors: | Zhiya Xu, Huilan Li, Xinyi Yu, Jia Luo, Zanling Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2340144 |
Similar Items
-
Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors
by: Atsumasa Kurozumi, et al.
Published: (2021-05-01) -
Hemophagocytic Lymphohistiocytosis as Initial Presentation of Malignancy in Pediatric Patients: Rare but Not to Be Ignored
by: Hye-ji Han, et al.
Published: (2021-11-01) -
Diagnosing Hemophagocytic Lymphohistiocytosis with Machine Learning: A Proof of Concept
by: Thomas El Jammal, et al.
Published: (2022-10-01) -
Immune checkpoint inhibitor‐related haemophagocytic lymphohistiocytosis in a patient with non‐small cell lung carcinoma
by: Setsuko Oyama, et al.
Published: (2023-04-01) -
Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients
by: Shuyan Yao, et al.
Published: (2023-12-01)